Shenzhen Glory Medical Co.,Ltd.

Simbol: 002551.SZ

SHZ

3.25

CNY

Tržna cena danes

  • -16.6251

    Razmerje P/E

  • 0.6657

    Razmerje PEG

  • 2.75B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Shenzhen Glory Medical Co.,Ltd. (002551-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Shenzhen Glory Medical Co.,Ltd. (002551.SZ). Prihodki podjetja prikazujejo povprečje 1100.394 M, ki je 0.158 % gowth. Povprečni bruto dobiček za celotno obdobje je 277.046 M, ki je 0.142 %. Povprečno razmerje bruto dobička je 0.291 %. Rast čistega dobička za lanskoletno poslovanje podjetja je -0.546 %, kar je enako 0.057 % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Shenzhen Glory Medical Co.,Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini -0.077. Na področju kratkoročnih sredstev 002551.SZ znaša 1822.663 v valuti poročanja. Velik del teh sredstev, natančneje 818.199, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za -0.111%. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 269.544 v valuti poročanja. Ta številka pomeni medletno spremembo v višini -0.125%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 2614.169 v valuti poročanja. Letna sprememba tega vidika je -0.052%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 611.007, zaloge na 371.55, dobro ime pa na 1.43, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 280.36.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

3585.05818.2920.11088.9
1264.3
1062.7
460.3
763.9
523.9
385.9
558.1
650.3
890.6
879.8
84.7
63.2
46.2
44.2

balance-sheet.row.short-term-investments

1239.9327.9434.9292.5
121.1
295.4
15
-197.9
-143.3
0
-164.3
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

2874.55611653.9871.2
904.1
1005.4
1173
1135.4
1309
1059
701.1
514.8
396.6
217.2
138.7
124.3
127.5
95.3

balance-sheet.row.inventory

1558.23371.5416.8375.9
343.7
302.9
254.5
360.9
327
299.1
332.9
293.5
65.8
41.9
62.9
31.9
28.1
17.4

balance-sheet.row.other-current-assets

119.4121.937.457.4
99
111.7
133.6
159.5
188.3
316
72.6
18.8
-36.9
-13
-10.1
-21.4
-29.2
-27.5

balance-sheet.row.total-current-assets

8137.231822.72028.22393.4
2611.1
2482.7
2021.4
2419.6
2348.3
2060
1664.7
1477.4
1316.1
1125.9
276.1
198
172.6
129.4

balance-sheet.row.property-plant-equipment-net

2001.82488.8556637.6
785.1
987.8
921.3
773.1
470.1
390.7
319.8
341.1
141.9
135.3
164.4
177.4
107.6
67.5

balance-sheet.row.goodwill

27.571.412.468.6
68.6
149.4
149.4
156.5
153.2
153.2
4
4
0
0
0
0
0.7
0

balance-sheet.row.intangible-assets

1099.93280.4510275.6
217.2
233.6
235.2
236.5
241.7
163
151.4
61.1
11.9
12.1
12.4
12.7
13
13.2

balance-sheet.row.goodwill-and-intangible-assets

1127.5281.8522.4344.2
285.8
383
384.6
392.9
394.9
316.2
155.4
65.1
11.9
12.1
12.4
12.7
13.7
13.2

balance-sheet.row.long-term-investments

437.58-194.7-288.190.1
110.9
-278.3
6
226
804
0
172.3
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

458.6103.9137.493.1
86.1
76.6
53.2
42
39.5
31.1
26.8
15
4.4
2.8
2.6
2
2.1
0.5

balance-sheet.row.other-non-current-assets

4052.721429.31304.61414.8
1182.3
1068.2
718.1
456.8
1.5
160.4
17.5
120.6
49.1
52.3
33.1
12.9
22.2
0

balance-sheet.row.total-non-current-assets

8078.222109.12232.32579.8
2450.2
2237.3
2083.2
1890.8
1709.9
898.3
691.8
541.7
207.3
202.5
212.5
205
145.5
81.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

16215.463931.74260.54973.2
5061.3
4720
4104.6
4310.4
4058.2
2958.3
2356.5
2019.2
1523.4
1328.4
488.6
403
318.1
210.7

balance-sheet.row.account-payables

1345.24381.9380447.1
466.9
641.3
697.9
890
892.7
592.3
459.5
339.5
126
42.2
41.7
32.4
23.4
12.4

balance-sheet.row.short-term-debt

146.1521.141.561.1
178.7
108.8
150.5
177.4
213.7
249.5
85.5
71.2
6.2
6.9
22.6
2.3
7.6
12.6

balance-sheet.row.tax-payables

296.1273.881.297.8
80.9
97.8
129.5
150.3
107.2
97.1
66.1
40.2
27.5
15.3
10.3
7.7
6.3
5.4

balance-sheet.row.long-term-debt-total

1106.62269.5290.6331.1
301.2
829
35.6
43
84.6
61
32.5
5.5
0
0
16.1
41.1
36.9
39.2

Deferred Revenue Non Current

324.5180.484.375
76.3
72.5
73.2
80.7
84.4
86.9
25.7
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.67---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

275.8424.2237.17.5
5.1
64.5
238.2
71.7
178.3
105.4
130
87.9
87.5
44.6
93.5
77.8
52
31.8

balance-sheet.row.total-non-current-liabilities

1443.15354.2379417.4
377.4
901.8
110.9
129.3
337.1
171.3
82.3
42.3
25
21
35.7
46.9
43.1
44.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

4829.3311841261.21526.8
1415.9
1903.9
1327
1637.2
1887.3
1376.9
899.6
684.2
303.8
147.8
212.6
173.8
145.9
127.7

balance-sheet.row.preferred-stock

126.6459.565.20
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

3379.16844.8844.8844.7
820.3
706
705.9
706
444.1
435.5
362.7
276.8
184.5
123
61.5
61.5
39.5
31.9

balance-sheet.row.retained-earnings

2055.96429.8578.7829.7
772.1
665.3
669.3
621.3
496.7
382.7
305.7
237.2
203.8
173
147.9
103.5
67
44.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

2544.16-59.5-65.242.5
68.7
83.7
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

2671.321339.61333.61403.8
1320.4
881.6
945.5
924.1
823.4
612.1
695.5
736.4
825.2
883.8
65.9
63.9
63.5
5.5

balance-sheet.row.total-stockholders-equity

10777.252614.22757.13120.7
2981.3
2336.6
2320.7
2251.4
1764.2
1430.4
1364
1250.4
1213.5
1179.7
275.3
228.9
170
81.8

balance-sheet.row.total-liabilities-and-stockholders-equity

16215.463931.74260.54973.2
5061.3
4720
4104.6
4310.4
4058.2
2958.3
2356.5
2019.2
1523.4
1328.4
488.6
403
318.1
210.7

balance-sheet.row.minority-interest

608.88133.6242.2325.7
664.1
479.5
456.9
421.8
406.8
151
92.8
84.6
6.2
0.9
0.7
0.3
2.2
1.2

balance-sheet.row.total-equity

11386.132747.82999.33446.4
3645.4
2816.1
2777.6
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

16215.46---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

1677.49133.1146.8382.6
232
17.1
21
28
660.7
8.1
8
7.8
0.1
0
0
0
0
0

balance-sheet.row.total-debt

1252.77290.6332.1392.2
479.9
937.9
186.2
220.3
298.3
310.6
117.9
76.7
6.2
6.9
38.7
43.3
44.5
51.8

balance-sheet.row.net-debt

-1092.38-199.7-153.2-404.2
-663.4
170.6
-274.1
-543.5
-225.6
-75.4
-440.1
-573.6
-884.4
-872.9
-46
-19.9
-1.7
7.5

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Shenzhen Glory Medical Co.,Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v -1.624. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko 0.006 v primerjavi s prejšnjim letom. Družba je pri naložbenju porabila neto denarna sredstva v višini -176847492.650 v valuti poročanja. To je premik za -0.686 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 125, 11.72 in -88.82, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo -163.95 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane 61.68, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-142.04-327.988369.9
76.4
134.7
189.2
136.3
143.5
111
77.5
59.6
44.3
46.8
39.5
24.6
22.1

cash-flows.row.depreciation-and-amortization

37.412576.755.1
39.6
32
30.4
29.6
27.5
24.1
13.4
11.8
11.5
10
3.7
3
1.9

cash-flows.row.deferred-income-tax

0-44.4-1.2-1.1
-25.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

044.41.21.1
25.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

37.9-90.457.930.6
-57.9
-226.7
-19.4
16.1
-50.4
-190.4
-201.9
-58.1
-117.9
-7
15.1
-35.3
0

cash-flows.row.account-receivables

29.17156.349.6116.2
183.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

8.73-55.9-38.6-41
-49.1
106.3
-34.7
-27.9
40.1
-40.4
-26.3
-23.9
21
-31.2
-3.8
-10.7
23.8

cash-flows.row.account-payables

0-146.448.1-43.5
-167
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-44.4-1.2-1.1
-25.1
-333
15.3
44.1
-90.5
-150
-175.6
-34.2
-138.9
24.2
18.9
-24.6
-23.8

cash-flows.row.other-non-cash-items

-7.05389.72041.9
81.7
102.2
35.2
99.3
97
41.3
26.4
18.4
5.6
1.3
-0.2
4
1.5

cash-flows.row.net-cash-provided-by-operating-activities

-160.91000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-48.06-57.3-430-254.2
-254.6
-357.3
-345
-141.8
-83.8
-77
-84.6
-12.8
-8.5
-15.4
-82.5
-39.3
-40.1

cash-flows.row.acquisitions-net

1.231.50.5-67.1
255
447.3
29.9
0
-114.1
-17.5
-41.5
0
0
0
0
-0.7
0

cash-flows.row.purchases-of-investments

-1064.1-865.4-1221-295.2
-817
-199
-685.2
-509.7
0
-37.7
0
-0.1
0
0
-4.2
0
0

cash-flows.row.sales-maturities-of-investments

1192.05732.61087.2473.3
541
237.9
777.5
127.9
6.5
17.5
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

84.2711.7-0.1-5.4
-254.6
-357.3
1.2
35
-256
-3.1
0
0
0.2
14.6
2.7
0
0

cash-flows.row.net-cash-used-for-investing-activites

83.61-176.8-563.4-148.6
-530.2
-228.3
-221.6
-488.6
-447.4
-117.9
-126.1
-12.9
-8.3
-0.9
-84
-39.9
-40.1

cash-flows.row.debt-repayment

-103.35-88.8-248.4-204.2
-358.5
-814.1
-1075.3
-1016.8
-626.2
-101.3
-31.6
-19.8
-31.8
-29.6
-23.4
-7.3
-2.3

cash-flows.row.common-stock-issued

0.19000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

-0.19000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-57.3-164-30.3-49.8
-74.2
-84.5
-35.2
-18.2
-50.1
-34.3
-42.8
-27.5
-16.9
-2.5
-3
-3.2
-2.3

cash-flows.row.other-financing-activites

48.0861.7287338.9
1084.6
787.1
1322.3
1354.2
719.5
131.9
30
23.1
876.7
26.3
41.3
54.5
47.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-45.97-191.18.384.9
652
-111.4
211.8
319.2
43.2
-3.8
-44.3
-24.2
828
-5.8
14.8
44
42.8

cash-flows.row.effect-of-forex-changes-on-cash

-8.86.14.7-20.3
2
-0.1
-7
2.8
-1.2
-0.8
-1.6
-0.4
0
-0.2
0
0.1
0

cash-flows.row.net-change-in-cash

-162.25-265.4-307.7413.6
263.6
-297.6
218.6
114.8
-187.9
-136.5
-256.6
-5.6
763.2
44.2
-11.1
0.5
28.3

cash-flows.row.cash-at-end-of-period

2036.43387.2652.6960.4
546.8
283.2
580.8
362.2
247.4
435.3
571.8
828.4
834.1
70.9
26.8
37.8
37.3

cash-flows.row.cash-at-beginning-of-period

2198.68652.6960.4546.8
283.2
580.8
362.2
247.4
435.3
571.8
828.4
834.1
70.9
26.8
37.8
37.3
9

cash-flows.row.operating-cash-flow

-160.9196.5242.6497.5
139.9
42.2
235.4
281.4
217.6
-14.1
-84.6
31.7
-56.5
51
58.1
-3.7
25.6

cash-flows.row.capital-expenditure

-48.06-57.3-430-254.2
-254.6
-357.3
-345
-141.8
-83.8
-77
-84.6
-12.8
-8.5
-15.4
-82.5
-39.3
-40.1

cash-flows.row.free-cash-flow

-208.9739.2-187.4243.3
-114.7
-315.1
-109.6
139.6
133.8
-91.1
-169.2
19
-65.1
35.6
-24.3
-42.9
-14.5

Vrstica izkaza poslovnega izida

Prihodki Shenzhen Glory Medical Co.,Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za -0.065%. Bruto dobiček podjetja 002551.SZ znaša 197.6. Odhodki iz poslovanja podjetja so 217.49 in so se v primerjavi s prejšnjim letom spremenili za -4.785%. Odhodki za amortizacijo znašajo 125, kar je -0.233% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 217.49, ki kaže -4.785% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja -154.184% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so -121.22, ki kažejo -154.184% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je -0.546%. Čisti prihodki v zadnjem letu so znašali -148.89.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

1155.161192.91275.71790.3
2267.3
1530.8
1630.4
2006.5
1946
1666.3
1166.8
730.9
421.3
348.4
270
208.5
138.1
116.4

income-statement-row.row.cost-of-revenue

972.72995.31053.81427.4
1572.6
1201
1228.5
1533.7
1471.1
1229.6
836.5
508.4
260.8
243.1
162.7
122.3
79.5
70.7

income-statement-row.row.gross-profit

182.44197.6221.9362.9
694.7
329.8
402
472.7
475
436.7
330.3
222.5
160.6
105.3
107.3
86.2
58.5
45.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

40.19---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

35.16---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

18.79---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-7.17-6.4115.4100.6
121.4
59
30.1
-0.1
7.8
4.5
2.5
7.3
3.3
1.7
0.7
0.5
-0.2
1.3

income-statement-row.row.operating-expenses

198217.5228.4267.9
311.5
203.2
197.4
228.3
245.1
238.8
176.2
127.3
89.9
68.2
49.1
39.7
26.1
20.1

income-statement-row.row.cost-and-expenses

1170.721212.81282.31695.3
1884
1404.2
1425.9
1762
1716.2
1468.4
1012.7
635.7
350.7
311.4
211.8
162
105.6
90.8

income-statement-row.row.interest-income

11.448.76.95.2
8.7
7.7
5.5
7.3
7
8.8
17.5
21.7
17
18.4
1.5
0.2
0.2
0.1

income-statement-row.row.interest-expense

1.7424.47.2
17
12.1
11.4
12
19
14.2
10.2
6.4
2.9
0.5
2.3
2.2
0.5
0.5

income-statement-row.row.selling-and-marketing-expenses

18.79---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

9.44-6.4-385.2-37.7
-1.8
-70.2
-51.6
-19.2
-67.7
-25.6
-20.7
0.6
1.9
15
-0.4
0.7
-3.9
-0.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-7.17-6.4115.4100.6
121.4
59
30.1
-0.1
7.8
4.5
2.5
7.3
3.3
1.7
0.7
0.5
-0.2
1.3

income-statement-row.row.total-operating-expenses

9.44-6.4-385.2-37.7
-1.8
-70.2
-51.6
-19.2
-67.7
-25.6
-20.7
0.6
1.9
15
-0.4
0.7
-3.9
-0.8

income-statement-row.row.interest-expense

1.7424.47.2
17
12.1
11.4
12
19
14.2
10.2
6.4
2.9
0.5
2.3
2.2
0.5
0.5

income-statement-row.row.depreciation-and-amortization

141.7395.912576.7
67.9
39.6
32
30.4
29.6
27.5
24.1
13.4
11.8
11.5
10
3.7
3
1.9

income-statement-row.row.ebitda-caps

14.82---
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-122.75-121.20.8126.7
370.3
141
122.8
225.4
154.4
167.8
131.3
88.6
69.2
50.3
57.1
46.7
28.8
23.4

income-statement-row.row.income-before-tax

-113.31-127.6-384.489.1
368.5
70.8
153
225.3
162.2
172.3
133.4
95.8
72.5
52
57.8
47.2
28.6
24.7

income-statement-row.row.income-tax-expense

36.633.2-56.51
-1.5
-5.6
18.2
36.1
25.8
28.9
22.4
18.3
12.9
7.7
11.1
7.7
4
2.6

income-statement-row.row.net-income

-142.04-148.9-327.988
369.9
59.8
97.7
175.2
114.2
119.1
102.2
73.8
58.3
44.2
46.4
39.9
24.1
22

Pogosto zastavljeno vprašanje

Kaj je Shenzhen Glory Medical Co.,Ltd. (002551.SZ) skupna sredstva?

Shenzhen Glory Medical Co.,Ltd. (002551.SZ) skupna sredstva so 3931719261.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 545763408.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.166.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je -0.299.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.125.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.102.

Kaj je Shenzhen Glory Medical Co.,Ltd. (002551.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je -148889156.240.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 290603679.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 217491767.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 616750849.000.